Exosome injection for early hip bone death
Part of Bones, joints & muscles clinical trials.
This trial tests a new treatment for early-stage hip bone death (avascular necrosis) where a substance called exosomes from stem cells is injected directly into the hip joint to see if it is safe and may help repair the bone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with non-traumatic hip bone death at an early stage (before the bone collapses).
- You have not had any prior injections or surgeries on the affected hip for this condition.
- You do not have active infections, autoimmune diseases, cancer, or severe bleeding disorders.
- You are willing to participate in long-term follow-up and can give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether injecting your own bone marrow into the hip can help heal early-stage osteonecrosis (bone death) before the bone collapses. It is for people who have not had prior hip surgery and do not have certain conditions like sickle cell disease.
This study is testing a new way to repair the damaged bone in your hip by using your own bone marrow stem cells. You may be a candidate if you have femoral head necrosis (hip bone death) that did not get better with standard treatments and you are otherwise healthy enough for surgery.
This trial studies whether a natural substance called exosomes, derived from stem cells, can help reduce pain and improve function in people with knee osteoarthritis. It may be an option if other treatments have not worked well for you.
This study looks for biological signs (biomarkers) that can help identify and understand osteonecrosis of the femoral head—a condition where bone in the hip dies. Researchers hope these signs will improve how doctors diagnose and treat the condition.
This study tests a new treatment called TG-C, which is an injection into the hip joint designed to help repair early cartilage damage and reduce pain. If you have early osteoarthritis in your hip and are looking for a non-surgical option, this might be a chance to try an experimental therapy.
This study tests whether breathing pure oxygen in a pressurized chamber before surgery can improve outcomes for people with early-stage avascular necrosis (bone death) in the hip. It may help preserve the hip and reduce the need for a hip replacement.
Hear when a new Non Traumatic Osteonecrosis of the Femoral Head (Hip) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.